Inhibitor Therapeutics (INTI, $0.05) was a top loser over the last three months, falling -3 to $0.05 per share. A.I.dvisor analyzed 830 stocks in the Biotechnology Industry for the 3-month period ending June 12, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. A.I.dvisor found 474 similar cases when INTI's price dropped within three months. In out of those 474 cases, INTI's price went up during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend reversal for INTI are